| EASL clinical practice guidelines: management of hepatitis C A Craxì, G Dusheiko, R Flisiak J hepatol 55 (2), 245-264, 2011 | 1913* | 2011 |
| Randomized study of peginterferon-α2a plus ribavirin vs peginterferon-α2b plus ribavirin in chronic hepatitis C MG Rumi, A Aghemo, GM Prati, R D'Ambrosio, MF Donato, R Soffredini, ... Gastroenterology 138 (1), 108-115, 2010 | 254 | 2010 |
| A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis R D'ambrosio, A Aghemo, MG Rumi, G Ronchi, MF Donato, V Paradis, ... Hepatology 56 (2), 532-543, 2012 | 253 | 2012 |
| Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ... Hepatology 53 (3), 791-799, 2011 | 227 | 2011 |
| EASL recommendations on treatment of hepatitis C 2014. European Association for The Study of The Liver Journal of hepatology 61 (2), 373, 2014 | 197 | 2014 |
| EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version) CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017 | 176 | 2017 |
| Genetic variation in the interleukin‐28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection F Marabita, A Aghemo, S De Nicola, MG Rumi, C Cheroni, R Scavelli, ... Hepatology 54 (4), 1127-1134, 2011 | 143 | 2011 |
| EASL recommendations on treatment of hepatitis C 2015 JM Pawlotsky, A Aghemo, D Back, G Dusheiko, X Forns, M Puoti, ... J hepatol 63 (1), 199-236, 2015 | 138 | 2015 |
| New horizons in hepatitis C antiviral therapy with direct‐acting antivirals A Aghemo, R De Francesco Hepatology 58 (1), 428-438, 2013 | 124 | 2013 |
| Recommendations for the management of hepatitis C virus infection among people who inject drugs J Grebely, G Robaeys, P Bruggmann, A Aghemo, M Backmund, ... International Journal of Drug Policy 26 (10), 1028-1038, 2015 | 120 | 2015 |
| A review of the treatment of chronic hepatitis C virus infection in cirrhosis E Vezali, A Aghemo, M Colombo Clinical therapeutics 32 (13), 2117-2138, 2010 | 119 | 2010 |
| Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method A Tripodi, M Primignani, L Lemma, V Chantarangkul, A Dell'Era, ... Hepatology 52 (1), 249-255, 2010 | 118 | 2010 |
| Trunnionosis: a pain in the neck PS Pastides, M Dodd, KM Sarraf, CA Willis-Owen World journal of orthopedics 4 (4), 161, 2013 | 110* | 2013 |
| Treatment with ledipasvir–sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial M Colombo, A Aghemo, H Liu, J Zhang, H Dvory-Sobol, R Hyland, C Yun, ... Annals of internal medicine 166 (2), 109-117, 2017 | 101 | 2017 |
| Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 S De Nicola, A Aghemo, M Grazia Rumi, E Galmozzi, L Valenti, ... Hepatology 55 (2), 336-342, 2012 | 96 | 2012 |
| The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response R D’Ambrosio, A Aghemo, M Fraquelli, MG Rumi, MF Donato, V Paradis, ... Journal of hepatology 59 (2), 251-256, 2013 | 94 | 2013 |
| Hepatitis C virus treatment in the real world: optimising treatment and access to therapies F Zoulim, TJ Liang, AL Gerbes, A Aghemo, S Deuffic-Burban, G Dusheiko, ... Gut 64 (11), 1824-1833, 2015 | 93 | 2015 |
| Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy J Iwamoto, Y Saito, A Honda, Y Matsuzaki World Journal of Gastroenterology: WJG 19 (11), 1673, 2013 | 91* | 2013 |
| EASL recommendations on treatment of hepatitis C 2016 EASL J Hepatol 63 (1), 199-236, 2015 | 87 | 2015 |
| Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management M Viganò, E Degasperi, A Aghemo, P Lampertico, M Colombo Expert opinion on biological therapy 12 (2), 193-207, 2012 | 84 | 2012 |
